U.S. STEM CELL, INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2011-09-06: Form 8-K; Period of report 2010-08-30; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2011-06-21: Form 8-K; Period of report 2011-06-15; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; Details 1.01.
- 2011-05-25: Form 8-K; Period of report 2011-05-16; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; Details 1.01.
- 2011-04-22: Form 8-K; Period of report 2011-04-18; Description 1.02 Termination of a Material Definitive Agreement; Details 1.02.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2011-09-06 | 8-K | 2010-08-30 | 7.01 Regulation FD Disclosure | 7.01 Regulation FD Disclosure. | d28625.htm |
| 2011-06-21 | 8-K | 2011-06-15 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. 3.02 On June 15, 2011, BlueCrest Venture Finance Master Fund Limited (“BlueCrest”) agreed with the Company and Lotus Funding Group, LLC (“Lotus”) to split the note evidencing the BlueCrest Loan originated May 31, 2007 into two notes aggregating the outstanding principal balance, with the new note being in the principal amount of $139,729.82 (the “New Note”). | d28341.htm |
| 2011-05-25 | 8-K | 2011-05-16 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. 3.02 On May 16, 2011, BlueCrest Venture Finance Master Fund Limited (“BlueCrest”) agreed with the Company and Magna Group, LLC (“Magna”) to split the note evidencing the BlueCrest Loan originated May 31, 2007 into two notes aggregating the outstanding principal balance, with the new note being in the principal amount of $139,729.82 (the “New Note”). | d28261.htm |
| 2011-04-22 | 8-K | 2011-04-18 | 1.02 Termination of a Material Definitive Agreement | 1.02 On January 23, 2011, Bioheart, Inc. (the “Company”) announced that it had entered into a subscription agreement with Anc Bio Holdings, Inc. (“ANC”), and a subscription agreement with one of its U.S. agents, Bioheart Florida, LLC (“BF”) for a $4 million equity investment, in the aggregate (collectively, the “Agreements”). | d28136_8k.htm |
| 2011-03-11 | 8-K | 2011-03-05 | 8.01 Other Events | 8.01 On January 23, 2011, Bioheart, Inc. (the “Company”) announced in the Company’s Current Report on Form 8-K filed with the SEC that it has entered into a subscription agreement with Anc Bio Holdings, Inc., a South Korean biomedical company, and a subscription agreement with one of its U.S. agents, Bioheart Florida, LLC for a $4 million equity investment, in the aggregate. | d27977.htm |
| 2011-02-23 | 8-K | 2011-02-20 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On February 20, 2011 (the “Resignation Date”), Jewett, Schwartz, Wolfe & Associates (“JSW”) advised Bioheart, Inc. (the “Company”) that its audit practice was acquired by RBSM LLP (“RBSM”), an independent registered public accounting firm. | d27928.htm |
| 2011-02-15 | 8-K | 2011-02-09 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On February 9, 2011, the Board of Directors of Bioheart, Inc. (the “Company”) appointed Ariel Quiros to serve as a director of the Company. | d27903.htm |
| 2011-01-25 | 8-K | 2011-01-23 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 Under the terms of its subscription agreement with Anc Bio Holdings, Inc. (“ABH”), the Company has agreed that, following its receipt of the first installment payment, the Company will cause a vacancy on the Company’s Board of Directors to be filled by one person designated by ABH. 8.01 On January 24, 2011, the Company issued a press release with regard to these transactions. | d27799.htm |
| 2011-01-12 | 8-K | 2011-01-06 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 3.02 On December 31, 2009, the Company and BlueCrest Venture Finance Master Fund Limited (“BlueCrest”) entered into an Amendment to Loan and Security Agreement, amending that certain loan from BlueCrest to the Company originated as of May 31, 2007 (the “Loan”). 7.01 On January 10, 2011, Bioheart, Inc. (the “Company”) closed its current offering under Regulation D (the “Offering”). | d27757_8k.htm |